BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37164664)

  • 1. Comprehensive Cancer Genomic Profiling of Liver Metastasis Led to the Unexpected Identification of Colorectal Cancer.
    Miyamoto H; Kawakami F; Abe S; Sugita H; Matsui H
    Intern Med; 2024 Jan; 63(1):63-70. PubMed ID: 37164664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subclonal Genomic Architectures of Primary and Metastatic Colorectal Cancer Based on Intratumoral Genetic Heterogeneity.
    Kim TM; Jung SH; An CH; Lee SH; Baek IP; Kim MS; Park SW; Rhee JK; Lee SH; Chung YJ
    Clin Cancer Res; 2015 Oct; 21(19):4461-72. PubMed ID: 25979483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative genomic analysis of primary and synchronous metastatic colorectal cancers.
    Lee SY; Haq F; Kim D; Jun C; Jo HJ; Ahn SM; Lee WS
    PLoS One; 2014; 9(3):e90459. PubMed ID: 24599305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic alterations accompanying tumour evolution in colorectal cancer: tracking the differences between primary tumours and synchronous liver metastases by whole-exome sequencing.
    Mogensen MB; Rossing M; Østrup O; Larsen PN; Heiberg Engel PJ; Jørgensen LN; Hogdall EV; Eriksen J; Ibsen P; Jess P; Grauslund M; Nielsen HJ; Nielsen FC; Vainer B; Osterlind K
    BMC Cancer; 2018 Jul; 18(1):752. PubMed ID: 30029640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Mutation of
    Sakai E; Nakayama M; Oshima H; Kouyama Y; Niida A; Fujii S; Ochiai A; Nakayama KI; Mimori K; Suzuki Y; Hong CP; Ock CY; Kim SJ; Oshima M
    Cancer Res; 2018 Mar; 78(5):1334-1346. PubMed ID: 29282223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic and prognostic heterogeneity among RAS/BRAF
    Berg KCG; Brunsell TH; Sveen A; Alagaratnam S; Bjørnslett M; Hektoen M; Brudvik KW; Røsok BI; Bjørnbeth BA; Nesbakken A; Lothe RA
    Mol Oncol; 2021 Apr; 15(4):830-845. PubMed ID: 33325154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-cell DNA sequencing reveals a late-dissemination model in metastatic colorectal cancer.
    Leung ML; Davis A; Gao R; Casasent A; Wang Y; Sei E; Vilar E; Maru D; Kopetz S; Navin NE
    Genome Res; 2017 Aug; 27(8):1287-1299. PubMed ID: 28546418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.
    Tsilimigras DI; Ntanasis-Stathopoulos I; Bagante F; Moris D; Cloyd J; Spartalis E; Pawlik TM
    Surg Oncol; 2018 Jun; 27(2):280-288. PubMed ID: 29937183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genomics of liver metastases from colon and rectal cancer: An Invited Commentary (invitation from Lee Ocuin, MD and Kevin Behrns, MD) for the special issue of "Management of Advanced Primary and Secondary Liver Malignancies".
    Schwantes IR; Mayo SC
    Surgery; 2023 Aug; 174(2):422-424. PubMed ID: 37183133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic profiling of sporadic liver metastatic colorectal cancer.
    González-González M; Gutiérrez ML; Sayagués JM; Muñoz-Bellvís L; Orfao A
    Semin Cancer Biol; 2021 Jun; 71():98-108. PubMed ID: 32485312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P53 mutations in primary tumors and subsequent liver metastases are related to survival in patients with colorectal carcinoma who undergo liver resection.
    Yang Y; Forslund A; Remotti H; Lönnroth C; Andersson M; Brevinge H; Svanberg E; Lindnér P; Hafström L; Naredi P; Lundholm K
    Cancer; 2001 Feb; 91(4):727-36. PubMed ID: 11241240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FBXW7 missense mutation: a novel negative prognostic factor in metastatic colorectal adenocarcinoma.
    Korphaisarn K; Morris VK; Overman MJ; Fogelman DR; Kee BK; Raghav KPS; Manuel S; Shureiqi I; Wolff RA; Eng C; Menter D; Hamilton SR; Kopetz S; Dasari A
    Oncotarget; 2017 Jun; 8(24):39268-39279. PubMed ID: 28424412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic ALK Fusion in Rare and Aggressive Subtype of Colorectal Adenocarcinoma as a Potential Therapeutic Target.
    Yakirevich E; Resnick MB; Mangray S; Wheeler M; Jackson CL; Lombardo KA; Lee J; Kim KM; Gill AJ; Wang K; Gowen K; Sun J; Miller VA; Stephens PJ; Ali SM; Ross JS; Safran H
    Clin Cancer Res; 2016 Aug; 22(15):3831-40. PubMed ID: 26933125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative evidence for early metastatic seeding in colorectal cancer.
    Hu Z; Ding J; Ma Z; Sun R; Seoane JA; Scott Shaffer J; Suarez CJ; Berghoff AS; Cremolini C; Falcone A; Loupakis F; Birner P; Preusser M; Lenz HJ; Curtis C
    Nat Genet; 2019 Jul; 51(7):1113-1122. PubMed ID: 31209394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic characterization of liver metastases from colorectal cancer patients.
    Sayagués JM; Corchete LA; Gutiérrez ML; Sarasquete ME; Del Mar Abad M; Bengoechea O; Fermiñán E; Anduaga MF; Del Carmen S; Iglesias M; Esteban C; Angoso M; Alcazar JA; García J; Orfao A; Muñoz-Bellvis L
    Oncotarget; 2016 Nov; 7(45):72908-72922. PubMed ID: 27662660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity.
    Moosavi SH; Eide PW; Eilertsen IA; Brunsell TH; Berg KCG; Røsok BI; Brudvik KW; Bjørnbeth BA; Guren MG; Nesbakken A; Lothe RA; Sveen A
    Genome Med; 2021 Sep; 13(1):143. PubMed ID: 34470666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing.
    Kovaleva V; Geissler AL; Lutz L; Fritsch R; Makowiec F; Wiesemann S; Hopt UT; Passlick B; Werner M; Lassmann S
    Mol Cancer; 2016 Oct; 15(1):63. PubMed ID: 27756406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signet ring cell colorectal cancer: genomic insights into a rare subpopulation of colorectal adenocarcinoma.
    Korphaisarn K; Morris V; Davis JS; Overman MJ; Fogelman DR; Kee BK; Dasari A; Raghav KPS; Shureiqi I; Trupti M; Wolff RA; Eng C; Menter DG; Hamilton S; Kopetz S
    Br J Cancer; 2019 Sep; 121(6):505-510. PubMed ID: 31406299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Genomic Profiling (CGP)-Informed Personalized Molecular Residual Disease (MRD) Detection: An Exploratory Analysis from the PREDATOR Study of Metastatic Colorectal Cancer (mCRC) Patients Undergoing Surgical Resection.
    Lonardi S; Nimeiri H; Xu C; Zollinger DR; Madison RW; Fine AD; Gjoerup O; Rasola C; Angerilli V; Sharma S; Wu HT; Palsuledesai CC; Malhotra M; Aleshin A; Loupakis F; Renkonen E; Hegde P; Fassan M
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histologic features and genomic alterations of primary colorectal adenocarcinoma predict growth patterns of liver metastasis.
    Wu JB; Sarmiento AL; Fiset PO; Lazaris A; Metrakos P; Petrillo S; Gao ZH
    World J Gastroenterol; 2019 Jul; 25(26):3408-3425. PubMed ID: 31341365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.